| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash | 1,037,094 | 685,229 | ||
| Prepaid expenses and other assets | 925,821 | 1,216,851 | ||
| Due from related party-Related Party | 158,819 | 158,819 | ||
| Total current assets | 2,121,734 | 2,060,899 | ||
| Property and equipment, net | 163,930 | 164,448 | ||
| Right-of-use assets - operating leases | 1,451,198 | 1,477,905 | ||
| Deferred offering costs | 190,923 | - | ||
| Other assets | 565,884 | 565,884 | ||
| Total assets | 4,493,669 | 4,269,136 | ||
| Accounts payable | 3,311,931 | 4,240,302 | ||
| Accrued expenses and other liabilities | 1,196,644 | 1,612,920 | ||
| Operating lease liabilities | 327,740 | 327,740 | ||
| Notes payable | 1,651,000 | 1,651,000 | ||
| Due to related party-Related Party | 250,000 | 250,000 | ||
| Total current liabilities | 6,737,315 | 8,081,962 | ||
| Loan agreement | 4,400,000 | 4,400,000 | ||
| Operating lease liabilities | 1,150,476 | 1,177,183 | ||
| Derivative warrant liabilities | 29,774 | 94,733 | ||
| Total liabilities | 12,317,565 | 13,753,878 | ||
| Preferred stock, value-Series APreferred Stock | 2,799,990 | 2,799,990 | ||
| Preferred stock, value-Series CPreferred Stock | 6,000,000 | 6,000,000 | ||
| Common stock, 0.0001 par value 800,000,000 shares authorized 197,391,411 and 177,991,365 shares issued and outstanding at september 30, 2025 and december 31, 2024 | 19,740 | 19,370 | ||
| Additional paid-in capital | 118,339,343 | 110,952,055 | ||
| Accumulated deficit | -134,982,969 | -129,256,157 | ||
| Total stockholders deficit | -7,823,896 | -9,484,742 | ||
| Total liabilities and stockholders deficit | 4,493,669 | 4,269,136 | ||
Tevogen Bio Holdings Inc. (TVGNW)
Tevogen Bio Holdings Inc. (TVGNW)